News

Filter

Current filters:

BayerDiabetesVaccines

1 to 9 of 95938 results

USIBC concludes successful pharmaceutical mission to India

28-08-2014

The US-India Business Council (USIBC) has concluded its Pharmaceutical Executive Mission to Delhi, India.…

IndiaPatentsPharmaceuticalPricingUSA

AusBiotech welcomes Greens' push for quarterly payments on R&D Tax Incentive

AusBiotech welcomes Greens' push for quarterly payments on R&D Tax Incentive

28-08-2014

Trade group AusBiotech says it fully supports the Australian Greens’ moving of an amendment in the…

AustraliaBiotechnologyFinancialResearch

China monoclonal antibody research forecast to increase

China monoclonal antibody research forecast to increase

28-08-2014

Several Chinese large-scale pharmaceutical enterprises have devoted themselves to research and development…

BiosimilarsBiotechnologyChinaHengrui MedicineMarkets & MarketingQilu PharmResearchShanghai Pharmaceuticals

NHS England boosts the Cancer Drugs Fund for more access to innovative medicines

NHS England boosts the Cancer Drugs Fund for more access to innovative medicines

28-08-2014

The National Health Service England has pledged to boost the Cancer Drugs Fund by £160 million ($265…

Cancer Drugs FundNHS EnglandOncologyPharmaceuticalRegulationUK

BTG and SciClone's DC Bead liver cancer therapy approved in China

BTG and SciClone's DC Bead liver cancer therapy approved in China

28-08-2014

UK specialist health care company BTG and its partner, China-focused US specialty drugmaker SciClone…

BTGChinaDC BeadHepatologyOncologyPharmaceuticalSciClone PharmaSciClone Pharmaceuticals

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

28-08-2014

Physicians across six different specialties expect that they will base prescribing decisions for biosimilars…

BiosimilarsBiotechnologyDecision Resources GroupMarkets & Marketing

UK NICE wants more info on type 2 diabetes drug Jardiance

UK NICE wants more info on type 2 diabetes drug Jardiance

28-08-2014

In a new draft guidance issued today, the UK drugs watchdog the National Institute for Health and Care…

Boehringer IngelheimDiabetesEli LillyJardiancePharmaceuticalPricingRegulationUK

1 to 9 of 95938 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top